128 related articles for article (PubMed ID: 710466)
1. Urinary fibrinogen degradation products (FDP) in bladder cancer.
Martínez-Piñeiro JA; Pertusa C; Maganto E; Zancajo VG; Magallon M; Losada G; Ortega F
Eur Urol; 1978; 4(5):348-50. PubMed ID: 710466
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of urinary fibrinogen degradation products in bladder carcinoma.
Alsabti EA
Eur Surg Res; 1979; 11(3):185-90. PubMed ID: 510327
[TBL] [Abstract][Full Text] [Related]
3. Further study of fibrinogen degradation products in bladder cancer detection.
Wajsman Z; Williams PD; Greco J; Murphy GP
Urology; 1978 Dec; 12(6):659-61. PubMed ID: 741544
[TBL] [Abstract][Full Text] [Related]
4. A multicenter trial evaluation of the fibrin/fibrinogen degradation products test for detection and monitoring of bladder cancer.
Schmetter BS; Habicht KK; Lamm DL; Morales A; Bander NH; Grossman HB; Hanna MG; Silberman SR; Butman BT
J Urol; 1997 Sep; 158(3 Pt 1):801-5. PubMed ID: 9258086
[TBL] [Abstract][Full Text] [Related]
5. The utility of fibrin/fibrinogen degradation products in superficial bladder cancer.
Tsihlias J; Grossman HB
Urol Clin North Am; 2000 Feb; 27(1):39-46. PubMed ID: 10696243
[TBL] [Abstract][Full Text] [Related]
6. Specific identification of urinary fibrinogen, fibrinogen degradation products, and cross-linked fibrin degradation products in renal diseases and after renal allotransplantation.
Scott WL; Francis CW; Knutson DW; Marder VJ
J Lab Clin Med; 1986 Jun; 107(6):534-43. PubMed ID: 3519810
[TBL] [Abstract][Full Text] [Related]
7. Urinary fibrin/fibrinogen degradation products in transitional cell carcinoma of the bladder.
Ewing R; Tate GM; Hetherington JW
Br J Urol; 1987 Jan; 59(1):53-8. PubMed ID: 3828688
[TBL] [Abstract][Full Text] [Related]
8. [The investigation on early diagnosis of the bladder tumor. I: A study on urinary cytology and urinary fibrin/fibrinogen degradation products (FDP) assay in patient with bladder tumor (author's transl)].
Tanahashi T
Nihon Hinyokika Gakkai Zasshi; 1979 May; 70(5):553-62. PubMed ID: 470263
[No Abstract] [Full Text] [Related]
9. Origin of urinary fibrin-fibrinogen degradation products in renal glomerular disease.
Hall CL; Blainey JD; Gaffney PJ
Nephron; 1979; 23(1):6-9. PubMed ID: 450168
[TBL] [Abstract][Full Text] [Related]
10. [Significance of urinary fibrin/fibrinogen degradation products (FDP) measured by highly sensitive ELISA method in various renal diseases].
Shibata T; Sumie A; Ishii T; Tomo T; Magari Y; Sato J; Yasumori R; Nasu M
Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):687-94. PubMed ID: 8377281
[TBL] [Abstract][Full Text] [Related]
11. The value of urinary fibrin/fibrinogen degradation products as tumor markers in urothelial carcinoma.
Jayachandran S; Unni Mooppan MM; Wax SH; Kim H
J Urol; 1984 Jul; 132(1):21-3. PubMed ID: 6726955
[TBL] [Abstract][Full Text] [Related]
12. Significance of urinary fibrin/fibrinogen degradation products in renal diseases measured by a highly sensitive ELISA.
Shibata T; Magari Y; Perparim K; Sumie A; Ishii T; Tomo T; Sato J; Yasumori R; Nasu M
Nephron; 1995; 69(1):54-8. PubMed ID: 7891798
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic values of urine CYFRA21-1, NMP22, UBC, and FDP for the detection of bladder cancer.
Jeong S; Park Y; Cho Y; Kim YR; Kim HS
Clin Chim Acta; 2012 Dec; 414():93-100. PubMed ID: 22944145
[TBL] [Abstract][Full Text] [Related]
14. [The usefulness of urinary FDP in the diagnosis of bladder cancer: comparison with NMP22, BTA and cytology].
Oeda T; Manabe D
Nihon Hinyokika Gakkai Zasshi; 2001 Jan; 92(1):1-5. PubMed ID: 11235137
[TBL] [Abstract][Full Text] [Related]
15. Significance of urinary fibrin/fibrinogen degradation products (FDP) D-dimer measured by a highly sensitive ELISA method with a new monoclonal antibody (D-D E72) in various renal diseases.
Shibata T; Magari Y; Kamberi P; Ishii T; Tomo T; Yasumori R; Nasu M
Clin Nephrol; 1995 Aug; 44(2):91-5. PubMed ID: 8529315
[TBL] [Abstract][Full Text] [Related]
16. Fragments of urinary fibrin/fibrinogen degradation products and cross-linked fibrin degradation products in various renal diseases.
Taira K; Matsunaga T; Kawahara S; Sakamoto S; Kamitsuji H
Thromb Res; 1989 Feb; 53(4):367-77. PubMed ID: 2929008
[TBL] [Abstract][Full Text] [Related]
17. A correlative study on urinary cytology and FDP with cystoscopy and pathology in the urinary bladder cancers.
Tanahashi T; Matsumura Y; Ohmori H; Tanaka T
Acta Med Okayama; 1978 Jun; 32(2):139-46. PubMed ID: 150199
[TBL] [Abstract][Full Text] [Related]
18. Urinary fibrin/fibrinogen degradation product E (FDP-E) measured by a highly sensitive ELISA method in renal diseases.
Shibata T; Magari Y; Mizunaga S; Ishii T; Tomo T; Yasumori R; Nasu M; Taguchi T
Nephron; 1998 Aug; 79(4):494-5. PubMed ID: 9689177
[No Abstract] [Full Text] [Related]
19. [Urinary cross-linked FDP in various renal diseases].
Inuma H
Nihon Jinzo Gakkai Shi; 1994 Feb; 36(2):146-57. PubMed ID: 8139147
[TBL] [Abstract][Full Text] [Related]
20. Assessment of fibrin-fibrinogen degradation products (Accu-Dx) test in bladder cancer patients.
Topsakal M; Karadeniz T; Anaç M; Dönmezer S; Besisik A
Eur Urol; 2001 Mar; 39(3):287-91. PubMed ID: 11275721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
